Collaborative Nature Communications study with The University of Queensland, Yale School of Medicine, and Nucleai examines how tumor cell positioning and glucose use predict which NSCLC patients ...

Enterprise architecture is intended to guide long-term decision-making, reduce risk, and align technology with business priorities, yet many EA practices struggle to move beyond conceptual influence.

While the latest UK Government report into animal testing was keen to highlight a (very slight) decrease from 2.67 million ...

Computational pathology is becoming increasingly important in helping deliver precision medicine to a wider range of patients. Experts at the 37th European Congress of Pathology in Vienna discussed ...

Nearly 40% of new cancer cases worldwide are potentially preventable, according to one of the first investigations 1 of its ...

Nearly 40% of new cancer cases worldwide in 2022 may be associated with modifiable risk factors, according to an analysis of 36 cancer types from 185 countries. The findings suggest that reducing ...

Transit Technologies, a leading provider of software solutions for modern transit systems, today announced the appointment of ...

Cancer biology is a rapidly evolving field, with pathology and biomarker research at the forefront of innovations in ...

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage ...

Metastasis-directed therapy (MDT) delivered via stereotactic body radiotherapy has gained substantial attention over the past decade. Landmark trials such as STOMP1 and ORIOLE2 fundamentally shifted ...

Along with ongoing wars, territorial disputes, and instability in regions such as the Middle East, Europe, Latin America, and parts of Africa, there are continued changes and power shifts in the ...

In the era of personalized oncology, implementation of reliable biomarkers with prognostic and predictive value is necessary, the latter being most ...